Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Pacific Biosciences

Explore full profile

Biotechnology company manufacturing systems for gene sequencing and real-time biological observations

Menlo Park, United StatesFounded 2004Biotech & Life Sciences
Valuation $861M Market cap · Aug/2026
Revenue $167M Latest reported FY

At a glance

Founded
2004
Headquarters
Menlo Park, United States
Listing
IPO 2010
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Pacific Biosciences.

See all news

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later14 investors entered at this stage

Talent

Book a demo to see the people
Employees mapped 587 incl. 6 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 8 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 8 startups shown

Former Pacific Biosciences employees who went on to found companies, sorted by Dealroom signal score.

CodePathEst. 2015
Tim LeeUnited States
Signal score83
PetDxEst. 2019
Art PolkUnited States
Signal score73
Cassidy BioEst. 2024
Ayal HendelIsrael
Signal score69
Menlo MicroEst. 2016
RSRisa StackUnited States
Signal score65
SightenEst. 2012
David VillagraUnited States
Signal score65
3 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
21 countries with
team presence
🇺🇸 United States82.5%
🇬🇧 United Kingdom3%
🇩🇪 Germany2.4%
🇨🇳 China2.3%
🇸🇬 Singapore1.8%
Top 5 of 21 shown
Web traffic by country
18K monthly visits
across markets
🇺🇸 United States101.1%
🇪🇸 Spain1.1%
Top 2 markets shown

Patents

Estimated portfolio value
$314M

245 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Pacific Biosciences was the backer or acquirer, 2021–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Pacific Biosciences's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Pacific Biosciences deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Pacific Biosciences's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Pacific Biosciences on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Pacific Biosciences on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles